Skip to content

Income Tax at other companies

BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
$35.68M-31.9%
Arrowhead Research logo
Arrowhead ResearchARWR
$7K-99.6%
United Therapeutics logo
United TherapeuticsUTHR
$43.4M-57.2%
Biogen logo
BiogenBIIB
$58.2M-17.7%
ALN
Alnylam PharmaceuticalsALNY
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX

Segments

By segment

See full
Life Science$347K-99.5%

Other financials

Income statement

See full
Revenue$272.6M-76.8%
Operating income$45.0M-95.4%
Net income-$2.8M-100%
EPS (diluted)-$0.03-100%

Balance sheet

See full
Cash & equivalents$834.0M-43.7%
Total debt$395.1M+0.1%
Total equity-$180.5M+2.9%
Total assets$2.9B+8.0%

Cash flow

See full
Operating cash flow-$59.0M-107%
CapEx$1.2M-30.6%
Free cash flow-$60.2M-107%

Valuation

See full
Market cap$6.55B+40.3%
Enterprise value$6.11B+77.3%
P/E
P/S7.9×+5.3×

Profitability

See full
Gross margin96%
Operating margin1.6%-38.7pp
Net margin42.3%+27.4pp
FCF margin39.1%+32.8pp

Returns & leverage

See full
Return on equity-216.7%
Debt / equity372.3×
Current ratio2.4×-1.5×

Where this comes from

Reported directly by PTC Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTC Therapeutics's income tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PTC Therapeutics's income tax?
PTC Therapeutics (PTCT) reported income tax of $347K in Q1 2026.
How has PTC Therapeutics's income tax changed year-over-year?
PTC Therapeutics's income tax decreased by 99.5% year-over-year, from $63.27M to $347K.
What is the long-term trend for PTC Therapeutics's income tax?
Over 2 years (2021 to 2023), PTC Therapeutics's income tax has grown at a 253.6% compound annual growth rate (CAGR), from $5.56M to -$69.51M.
What does income tax mean?
Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.